Endovascular therapies have evolved significantly within the last decade, due in large part to a proliferation of several innovative microsurgical device treatments. Conditions such as arteriovenous malformations (AVMs), strokes, aneurysms, carotid artery disease, and intracranial atherosclerotic disease (ICAD) can all be treated with today\u2019s minimally invasive techniques.<\/p>\n
In keeping with these advances, Zeus manufactures a range of catheter components and biomaterials that are particularly well-suited for the neurovascular system. Our PTFE StreamLiner\u2122 series<\/a> of catheter liners offers among the thinnest walls and tightest tolerances in the industry, with nominal wall thicknesses as low as 0.0004\u2033 (0.0102 mm) and tolerances approaching \u00b1 0.0002\u2033 (0.0051 mm).<\/p>\n Our other catheter components include an extensive range of jacketing, braiding, and fusing sleeves to create precise microcatheters capable of reaching narrow treatment sites. We also manufacture novel implantable biomaterial products with custom strength and degradation profiles that help clear blocked vessels and save lives.<\/p>\n At Zeus, we strive to meet the demands of the medical sector every day and improve the level of deliverable care. As part of that mission, we continually partner with engineers, researchers, and clinicians to address and provide solutions to the neurovascular market. We will work with you to advance your projects from design to production and can even assist with small-scale product assembly.<\/p>\nOur Team is Your Team<\/h3>\n